Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer’s Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota

<i>Faecalibacterium prausnitzii</i> is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

Harry Sokol, Bénédicte Pigneur, Laurie Watterlot et al. · Proceedings of the National Academy of Sciences · 2008 · 4.3K citations · Full text

Life Sciences, Immunology, Microbiology +17

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Jeff Sevigny, Ping Chiao, Thierry Bussière et al. · Nature · 2016 · 3.1K citations

Life Sciences, Neurology, Neuroscience +14

Gut Microbiota is Altered in Patients with Alzheimer’s Disease

Zhen‐Qian Zhuang, Lin‐Lin Shen, Weiwei Li et al. · Journal of Alzheimer s Disease · 2018 · 870 citations

Life Sciences, Microbiology, Neuroscience +17

An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers

Theresa R. Bomfim, Letícia Forny‐Germano, Luciana B. Sathler et al. · Journal of Clinical Investigation · 2012 · 824 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer’s disease animal model

Min‐Soo Kim, Yoonhee Kim, Hyunjung Choi et al. · Gut · 2019 · 606 citations

Life Sciences, Neurobiology, Neuroscience +17